Beese Fulmer Investment Management Inc. Purchases 511 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Beese Fulmer Investment Management Inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% during the fourth quarter, HoldingsChannel reports. The firm owned 23,271 shares of the healthcare conglomerate’s stock after acquiring an additional 511 shares during the period. Beese Fulmer Investment Management Inc.’s holdings in UnitedHealth Group were worth $11,772,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. AMF Tjanstepension AB boosted its holdings in UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after acquiring an additional 121,180 shares during the period. Hudson Value Partners LLC lifted its position in UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after buying an additional 82 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors increased its stake in shares of UnitedHealth Group by 11.2% during the third quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 2,367 shares of the healthcare conglomerate’s stock valued at $1,384,000 after purchasing an additional 238 shares in the last quarter. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at $32,000. Finally, CWM LLC increased its position in shares of UnitedHealth Group by 0.5% during the third quarter. CWM LLC now owns 99,275 shares of the healthcare conglomerate’s stock valued at $58,044,000 after acquiring an additional 504 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on UNH. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Barclays decreased their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $529.71 on Friday. The firm has a market capitalization of $487.48 billion, a price-to-earnings ratio of 34.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a 50 day moving average price of $532.43 and a 200 day moving average price of $564.77. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.83 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.